FolioLanternBeta
KROSKeros Therapeutics, Inc.

Esther Cho

Chief Legal Officer at Keros Therapeutics, Inc., as of Aug 20, 2026Sold $124K of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
36K
shares held after the latest filing, Keros Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
9.2K
shares sold, past 12 months
2
days with sales
$78K
largest single day, Feb 18, 2026
1
company filed for

Share of stake sold at Keros Therapeutics, Inc. is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFeb 2026: $78K to cover taxes$78KFebMarAprMayJunJulAug 2026: $46K to cover taxesAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Keros Therapeutics, Inc. (KROS)Chief Legal OfficerAug 15, 2025Aug 20, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.